Today is #WorldLungDay 🫁 📺 In this video, #lungcancer patient Elaine Lynch gives us an insight into the patient journey, as she shares her experiences of living with HER2-mutated #NSCLC Watch to find out: 🔸What it means to Elaine to live with a rare alteration of NSCLC

Catch up on the highlights from #ASCO25 with Prof. Mark Socinski as he reviews the latest data in oncogene-addicted #NSCLC Watch on YouTube here: youtube.com/watch?v=-w8gUk… #MedEd #OncTwitter #MedicalOncology Supported by an Independent Educational Grant from Bayer

Get the key clinical takeaways from the latest data from #WCLC25 📺 Dr Devika Das, MD, MSHQS, FASCO reviews data from Global TRUST-II SHERLOCK, REZILIENT1, SOHO-01 and Beamion LUNG-1 🤝 Endorsed by ICAN, International Cancer Advocacy Network Exon 20 Group, a multistakeholder organization Biomarker Collaborative & Lung Cancer Europe Supported by an Independent Educational

📺 In this video, lung cancer patient Elaine Lynch gives us an insight into the patient journey, as she shares her experiences of living with HER2-mutated NSCLC Watch to find out: 🔸What it means to Elaine to live with a rare alteration of NSCLC 🔸What she would like other

📢 Come and visit us in Berlin at #ESMO25! We'll be at Booth 4025 offering FREE profile headshots from our professional photographer & showcasing our range of high-quality Independent #MedicalEducation programmes across multiple therapy areas. See you there! #IME #MedTwitter

📣 Rare alterations of #NSCLC – video podcast Are pt needs matched by the support currently available? 📹Dr Joshua Sabari, MD & Debra Montague (President of Lung Cancer Europe & founder of UKALK+) share two perspectives: #MedOnc vs #PatientAdvocate Do they agree on what patients need?

On YouTube now: youtu.be/Z57cUtQx1BE?fe… Watch Dr Joshua Sabari in conversation with Debra Montague (@LungCancerEurope, ALK Positive UK). Gain the patient perspective while learning about diagnosis, biomarker testing & treatment of rare NSCLC alterations. Supported by an

Explore the latest data on oncogene-addicted #NSCLC from IASLC’s #WCLC2025 Experts bring you this video with PRECISION ONCOLOGY CONNECT #MedEd

Do the latest data on oncogene-addicted #NSCLC impact clinical practice? 📺Dr Devika Das, MD, MSHQS, FASCO shares her highlights from IASLC’s #WCLC2025 in this video 🤝 Endorsed by ICAN, International Cancer Advocacy Network Exon 20 Group, a multistakeholder organization Biomarker Collaborative & Lung Cancer Europe Supported by an Independent Educational Grant from

📢 Come and visit us in Berlin at #ESMO25! We'll be at Booth 4025 offering FREE profile headshots from our professional photographer, and showcasing our range of high-quality Independent #MedicalEducation programmes across multiple therapy areas. See you there! #IME

Rare alterations of NSCLC – video podcast Are pt needs matched by the support currently available? 📹Dr Joshua Sabari, MD & Debra Montague (President of Lung Cancer Europe & founder of UKALK+ ) share two perspectives: Med Onc vs Patient Advocate Do they agree on what patients need?

🔎Looking back at oncogene-addicted #NSCLC data presented at #ASCO25 Back in June, Prof. Mark Socinski joined us at ASCO to share his views on new #lungcancer data as it emerged from the congress. He reviewed data from: 🔸SOHO-01 & SOHO-02 🔸SACHI 🔸OptiTROP-Lung03

Dear Colleagues at #ESMO25 Dr Herbert Loong, MBBS, FASCO shares his perspectives on the latest data on oncogene-addicted non-small cell lung cancer (NSCLC) presented at ESMO 2025. Go to the COR2ED website to watch his video update and download the accompanying slides for more detailed insights.

Update from #ESMO25! 📺 Dr Herbert Loong, MBBS, FASCO reviews the latest data on oncogene-addicted #NSCLC from: OptiTROP-Lung04 SOHO-01 Beamion LUNG 1 LOXO-RAS-20001 FURMO-003 See more: cor2ed.com/n-connect/prog… 🤝 Endorsed by Exon 20 Group, a multistakeholder organization Biomarker Collaborative ICAN, International Cancer Advocacy Network Lung Cancer Europe Lung Cancer Research Foundation

Update from ESMO25! 📺 Dr Herbert Loong, MBBS, FASCO reviews the latest data on oncogene-addicted NSCLC from: OptiTROP-Lung04 SOHO-01 Beamion LUNG 1 LOXO-RAS-20001 FURMO-003 Endorsed by Exon 20 Group, a multistakeholder organization Biomarker Collaborative ICAN, International Cancer Advocacy Network Lung Cancer Europe Lung Cancer Research Foundation International Society of Liquid Biopsy Supported by an

Reviewing the latest data on oncogene-addicted #NSCLC 🔍 How will these data impact clinical practice? 📺 Dr Herbert Loong, MBBS, FASCO shares his highlights from #ESMO25 Get the slides for more detailed insights: cor2ed.com/n-connect/prog… 🤝Endorsed by Exon 20 Group, a multistakeholder organization Biomarker Collaborative ICAN, International Cancer Advocacy Network

THE #ESMO25 COMPLETE Newsletter by OncoAlert 🚨IS OUT NOW‼️ TO GET IT REGISTER at OncoAlert360.com OR oncoalert.m-pages.com/nhMpwe/oncoale… 5⃣0⃣of our pick of TOP Trials Presented in Berlin🇩🇪Divided by Tumor Type and with great video coverage by our collaborators at COR2ED

🎉 COR2ED now has over 20,000 YouTube subscribers! 🎉 LUNG CONNECT is an initiative of COR2ED - come and find us on YouTube! Join over 20k healthcare professionals who follow us on YouTube to stay up to date with high-quality, engaging medical education programmes from